The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 Summer Meeting | Challenges faced in the management of brain metastases and large cell neuroendocrine lung cancers
John Conibear, MBBCh, BSc, MSc, MRCP, FRCR, St Barts Health NHST, UK, talks on the current challenges faced on the management of brain metastases in patients with lung cancer presented at the BTOG 2022 Summer Meeting, highlighting the importance of individualized approaches to ensure the most appropriate and clinically effective treatment is selected at initial presentation. The challenges behind large cell neuroendocrine lung cancers were additionally reviewed. This interview took place at the BTOG 2022 Summer Meeting congress in London.
